Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Basilea Pharmaceutica is a Swiss-based biopharmaceutical company specializing in the development of innovative medicines. Its primary focus is addressing resistant bacterial and fungal infections, as well as advancing oncology through the creation of targeted therapeutic solutions.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Basilea Pharmaceutica is scheduled to report its next quarterly earnings on 08/18/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Basilea Pharmaceutica last reported quarterly earnings on 2/17/2026 (Q1 2026). Earnings per share (EPS) came in at 3.14 CHF.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.